Full Length Research Paper
References
|
Adeloye D, Ige JO, Aderemi AV, Adeleye N, Amoo EO, Auta A, Oni G (2017). Estimating the prevalence, hospitalization and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. British Medical Journal Open 7(5):e015424. |
|
|
Albers JJ, Warnick GR, Chang MC (1978). Quantitation of high-density lipoproteins. Lipids 13:926-932. |
|
|
Allain CC, Poon LS, Chan CS (1974). Enzymatic determination of total serum cholesterol Clinical Chemistry 20:470-475. |
|
|
Amaeze OU, Aderemi-Williams RI, Ayo-Vaughan MA, Ogundemuren DA, Ogunmola DS, Anyika EN (2018). Herbal medicine use among Type 2 diabetes mellitus patients in Nigeria: understanding the magnitude and predictors of use. International Journal of Clinical Pharmacy 40(3):580-588. |
|
|
Ambroz M, de Vries S, Vart P, Dullaart RP, Roeters van Lennep J (2021). Sex differences in lipid profile across the life span in patients with type 2 diabetes: A primary care-based study Journal of Clinical Medicine 10(11):2332. |
|
|
Amedu EI, Emejulu MJ, Aighewi LT (2020). Household Solid Waste Management Survey in Benin City Agglomeration, Edo State, Nigeria. Nigerian Research Journal of Engineering and Environmental Sciences 5(1):18-21. |
|
|
Aronson D, Rayfield EJ (2002). How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovascular Diabetology 1:1. |
|
|
Bays HE, McCarthy WJ, Henneman J (2014). The role of triglycerides in cardiovascular disease American Journal of Cardiology 113(10)1715-1721. |
|
|
Chait A, Bornfeldt KE (2009). Diabetes and atherosclerosis: is there a role for hyperglycemia? Atherosclerosis 205(1):1-6. |
|
|
Czech MP (2017): Insulin action and resistance in obesity and type 2 diabetes Nature Medicine 23:804-814. |
|
|
Dobiásová M, Frohlich J (2001). The atherogenic index of plasma: A useful measure of dyslipidemia in the assessment of cardiovascular risk. Clinical Chemistry and Laboratory Medicine 39(5):401-404. |
|
|
Dobiášová M, Frohlich J, Šedová M, Cheung MC, Brown BG (2011). Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. Journal of Lipid Research 52(3):566-571. |
|
|
Drew BG, Rye KA, Duffy SJ, Barter P, Kingwell BA (2012). The emerging role of HDL in glucose metabolism. Nature Reviews Endocrinology 8(4):237-245. |
|
|
Duran A (2021). Atherogenic index of plasma as a predictor of cardiovascular disease in type 2 diabetes mellitus. Journal of Diabetes Research Article ID 1765835. |
|
|
Emos ET, Ismaeel Y, Judith HH, Ibrahim AC, Victor BO (2021). Prevalence, Contributing Factors and Management Strategies (Self-Management Education) of Type 2 Diabetes Patients in Nigeria: A Review International Journal of Diabetes and Clinical Research 8(3):10-13. |
|
|
Funk SD, Yurdagul Jr A, Orr AW (2011). Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Journal of Diabetes Research 2011:1-12. |
|
|
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C (2020). Pathophysiology of type 2 diabetes mellitus International Journal of Molecular Sciences 21(17):6275. |
|
|
Igharo OG, Akinfenwa Y, Isara AR, Idomeh FA, Nwobi NL, Anetor JI, Osibanjo O (2020). Lipid profile and Atherogenic Indices in Nigerians Occupationally Exposed to e-waste: A Cardiovascular Risk Assessment Study PubMed 15(2):196-205. |
|
|
Jiang H, Zhang Y, Wang Y (2019). Glycation of apolipoprotein A-I impairs HDL function in type 2 diabetes. Diabetes Care 42(5):889-898. |
|
|
La Sala L, Prattichizzo F and Ceriello A (2019). The link between diabetes and atherosclerosis. European Journal of Preventive Cardiology 26(2_suppl):15-24. |
|
|
Mauvais-Jarvis F (2015). Sex differences in metabolic homeostasis, diabetes, and obesity Biology of Sex Differences, 6(1):1-14. |
|
|
Mora S, Rifai N and Buring JE (2014). Atherogenic index of plasma and the risk of cardiovascular disease. Journal of Clinical Lipidology 8(6):640-646 |
|
|
Okafor CL, Gezawa, ID and Sabir AA (2016). Diabetes prevalence and its predictors in Nigeria: a systematic review and meta-analysis Nigerian Journal of Clinical Practice 19(6):802-809. |
|
|
Olamoyegun MA, Oluyombo R, Asaolu SO (2016). Evaluation of dyslipidemia, lipid ratiosand atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria Annals of African medicine 15(4):194-199. |
|
|
Oyakhire F, Emokpae MA, Ogie E and Valentine EE (2021). Effect of diabetes mellitus on the excretory function of the liver Medical Laboratory Technology Journal 7(2):155-157. |
|
|
Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V (2020). The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation Frontiers in Immunology 11:900254. |
|
|
Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, Gao F, Yang L, Xu Y, Wu Y (2020). The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovascular Diabetology 19(1):23. |
|
|
Schettler G, Nussel E (1975). Methods for triglyceride Mediation and arbitration 10:25. |
|
|
Uloko AE, Musa BM, Ramalan MA, Gezawa ID, Puepet FH, Uloko AT, Borodo MM, Sada KB (2018). Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Therapy 9(3):1307-1316. |
|
|
Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y (2023). Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovascular diabetology 22(1):157. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
